Introduction to the role of microRNAs in cancer diagnosis, prognosis, and treatment [0.03%]
微小RNA在癌症诊断、预后及治疗中作用概述
Carlo Croce
Carlo Croce
Matteo S Carlino,Gerald B Fogarty,Georgina V Long
Matteo S Carlino
Brain metastases occur commonly in patients with metastatic melanoma, are associated with a poor prognosis, and cause significant morbidity. Both surgery and stereotactic radiosurgery are used to control brain metastases and, in selected pa...
Angela Hong,Gerald Fogarty
Angela Hong
Radiotherapy plays a vital role in the management of primary cutaneous melanoma in definitive, adjuvant, and palliative settings. The indications for radiation therapy in melanoma are expanding on the basis of recent clinical trials. The ad...
Diwakar Davar,Ahmad A Tarhini,John M Kirkwood
Diwakar Davar
Estimates from the U.S. Surveillance, Epidemiology, and End Results registry suggest that melanoma incidence will reach 70,230 cases in 2011, of whom 8790 will die. The rising incidence and predilection for young individuals makes this tumo...
Genevieve M Boland,Jeffrey E Gershenwald
Genevieve M Boland
The technique of lymphatic mapping and sentinel lymph node (SLN) biopsy for melanoma has emerged during the last 2 decades as a minimally invasive approach to evaluate regional lymph node basins in patients with intermediate- and high-risk ...
Anna M Leung,Danielle M Hari,Donald L Morton
Anna M Leung
Traditionally, distant metastatic melanoma has a poor prognosis owing to lack of efficacious, U.S. Food and Drug Administration-approved systemic therapy and the limited use of surgical resection as a therapeutic option. More recently, new ...
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook [0.03%]
自体肿瘤浸润性淋巴细胞过继T细胞治疗转移性黑色素瘤的现状和未来展望
Richard Wu,Marie-Andrée Forget,Jessica Chacon et al.
Richard Wu et al.
Immunotherapy using autologous T cells has emerged to be a powerful treatment option for patients with metastatic melanoma. These include the adoptive transfer of autologous tumor-infiltrating lymphocytes (TILs), T cells transduced with hig...
Targeting immune checkpoints: releasing the restraints on anti-tumor immunity for patients with melanoma [0.03%]
靶向免疫检查点:解除转移性黑色素瘤患者的抗肿瘤免疫反应限制
Michael A Postow,James Harding,Jedd D Wolchok
Michael A Postow
Insight into the mechanisms of anti-tumor immunity has generated great enthusiasm for the treatment of patients with advanced melanoma. Particularly, negative regulators of the immune system, called immunologic checkpoints, have been found ...
Scott E Woodman
Scott E Woodman
Uveal melanoma is the most common primary intraocular cancer in adults. Nearly half of primary uveal melanoma tumors metastasize, but there are currently no effective therapies for metastatic uveal melanoma. The recent discovery of mutation...
Michael A Davies
Michael A Davies
The PI3K (phosphatidylinositol 3-kinase)-AKT pathway is one of the most important signaling networks in cancer. There is growing evidence that activation of this pathway plays a significant role in melanoma, frequently in the setting of con...